How Zhang was paid
$8.3M in total for 2025, as reported in the Summary Compensation Table. Equity awards are valued at grant, not at what they turned out to be worth.
Named executive officers
| Executive | Salary | Bonus | Stock | Options | Incentive | Other | Total |
|---|---|---|---|---|---|---|---|
| Jack Yongfeng ZhangChief Executive Officer, President, Chief Scientific Officer and Director | $950,911 | $329,747 | $3,301,981 | $3,302,024 | $361,000 | $63,687 | $8,309,350 |
| William J. PetersChief Financial Officer, Executive Vice President of Finance, Treasurer, President of International Medication Systems, Limited, and Director | $649,846 | $370,308 | $1,043,982 | $1,044,022 | $73,000 | $57,524 | $3,238,682 |
| Mary Ziping LuoChief Operating Officer, Chief Scientist and Chairman | $775,120 | $288,923 | $1,391,976 | $1,392,030 | $128,000 | $55,029 | $4,031,078 |
| Rong ZhouSenior Executive Vice President of Production and President of Amphastar Nanjing Pharmaceuticals, Co., Ltd | $717,587 | $280,475 | $701,500 | $701,513 | $98,000 | $43,559 | $2,542,634 |
| Jacob LiawatidewiExecutive Vice President of Sales and Marketing, Executive Vice President of Corporate Administration Center and President of Amphastar France Pharmaceuticals, S.A.S. | $499,909 | $265,200 | $591,979 | $592,026 | $47,000 | $41,742 | $2,037,856 |
What changed and why
- $8.3MCEO total compensation increased to $8,309,350 in fiscal 2025.
- Stock and option awards represented the largest portion of CEO pay.
- 95%Stockholders approved the previous say-on-pay resolution with approximately 95% support.
- $61,658The median employee annual total compensation was $61,658.
- The estimated ratio of CEO to median employee pay was 135 to 1.
About this page
Figures are automated and can be wrong; check the filing for the exact numbers. Totals follow SEC rules, which value stock and option awards at grant. Read the DEF 14A proxy statement for footnotes and the compensation committee's full reasoning.